At Nova Leah, we believe in excellence through knowledge development, sharing and collaboration to enhance the security assurance of medical devices. Our platform, SelectEvidence® allows stakeholders to implement cybersecurity requirements for their devices using a proven standardized and collaborative framework. SelectEvidence® is supported by Machine Learning which automatically identifies technology specific vulnerabilities and associated, mitigating security controls. SelectEvidence® maintains full traceability from risk identification to risk treatment from requirements specification to product retirement.